A training programme on intellectual property organised by the United States with several partners to be held in Africa in April has been postponed under pressure to make the programme more transparent and representative of all stakeholders.

In the shadows of some of London’s tallest skyscrapers and richest banks lurks a disease borne of the poverty and squalor usually associated with the Victorian era rather than a 21st-century financial capital.

Over one hundred human rights NGOs, including some from Uganda, have petitioned the US government to stop a three-day Intellectual property summit set to take place in Cape Town, South Africa in April 2012.

Determine TB-LAM, a urine antigen test for pumonary tuberculosis screening, proved reasonably sensitive in HIV-positive people with low CD4 counts, according to results of a 500-patient study at an antiretroviral clinic in Gugulethu township, South Africa. Sensitivity improved when Determine TB-LAM was combined with sputum smear microscopy.

The European Medicines Agency (EMA)'s Committee for Medicinal Products for Human Use (CHMP) agrees with the World Health Organization (WHO) dosing recommendations for ethambutol, isoniazid, pyrazinamide, and rifampicin as first-line antituberculosis medicines used in children, according to new EMA dosing guidelines released February 17.

Last month, when a more resistant type of tuberculosis was reported from India, it threatened to take a little of the sheen away from the country's healthcare community that was in self-congratulatory mode for successfully controlling polio. Soon enough, Government authorities got involved — rapping the hospital that reported the highly resistant TB for creating a scare, and wrapping the incident in semantic knots.

Last year alone, 376 000 people with HIV started antiretroviral medication- over 100 000 more than the previous year.

It only takes an inexpensive digital X-ray detector to help stamp out a disease that is killing millions of people in developing countries, an award-winning University of Waterloo researcher says.

NAIROBI, Kenya, Feb 23 – The government has been urged to fast-track the construction of an isolation ward for TB patients in Kenya.

To combat the deadly combination of HIV/AIDS and tuberculosis (TB) decimating its population, a new TB testing center opened on Jan. 26, 2012, in Mbabane, Swaziland. It is a collaboration of the American Society for Clinical Pathology (ASCP), the U.S. Centers for Disease Control and Prevention (CDC), University Research Corporation, and Doctors Without Borders. The facility, with high technology laboratory equipment, access control, and computerized laboratory to match the requirements of the World Health Organization (WHO), is housed within the five-story National Reference Laboratory.